Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Revision of the ambulatory medical tariffs in Switzerland

The outpatient medical services are currently billed via TARMED, which includes all the benefits of compulsory health insurance. The need to revise the outdated TARMED exists, but it is incredibly ambitious to find a solution that constitutes an acceptable consensus for all tariff partners.

Ats-tms SA was founded at the beginning of 2016 by curafutura, the Federation of Swiss physicians (FMH), the association of Swiss hospitals (H+, who left ats-tms SA after the validation of benefit structure) and the medical tariff commission (MTK/CTM) in order to develop a thoroughly revised tariff structure for ambulatory medical benefits and to be able to update it regularly.

Ats-tms SA finalized the benefit structure in mid-September 2018 and has recently been approved by its board of directors. This fee structure will be submitted to the Federal Council as soon as it is finalized, most likely in spring 2019. The Federal Office for Public Health (FOPH) will be informed.

See the full report in French here.

See the renewed benefit structure in German here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.